Home > Blog > Shaping the future of myeloma together

1 min read

Shaping the Future of Myeloma, Together

Veristat-Oncology-Drug-Trials

Veristat, a full-service CRO, can guide you through the planning and development process to help you successfully bring a new myeloma cancer treatment to market. With 41% of our work in oncology trials and extensive experience with myeloma, Veristat can help advance your compound through the submission process. Our teams will collaborate to build the optimal program based upon the science of your product, while providing key functional services, including trial design, clinical monitoring, data management, medical writing and statistical consultation with regulatory representation.
Contact our team to learn more about our oncology experience, the work we have performed in the area of myeloma and how we can help you.
WORKING TOGETHER. The Veristat Oncology team: 
  • Embraces the science behind your product to foster and present your data as substantial evidence to key points and conclusions
  • Begins with the end in mind and provides comprehensive strategic guidance on the entire clinical program from beginning-to-end
  • Paves the way to success by designing the most optimal program and clinical trial design based upon the science of your product
  • Incorporates best practices and procedures to maximize data quality, safety, and regulatory compliance to industry standards
  • Works closely with you to custom-build your program and documentation to meet complex product and regulatory requirements
  • Leverages the latest technologies to best fit the oncology drug solutions you need

Through application of cutting-edge research, novel trial designs, and innovative approaches, Veristat delivers excellence throughout every aspect of an oncology trial.

 
STAY CONNECTED
Follow us on Twitter   View our profile on LinkedIn   Find us on Google+   Like us on Facebook

2 min read

Operationalizing Adaptive Design for FDA's One-Trial Era

Sep 22, 2026  Veristat Events

Operationalizing Adaptive Design for FDA's One-Trial Era

October 20, 2026 : 11:00 AM ET

On February 18, 2026, the FDA...

2 min read

Meet Veristat at the iC³ Life Science and Healthcare Innovation Summit

Aug 26, 2026  Veristat Events

Where Life Science Innovation Moves Forward

iC³ Life Science and Healthcare Innovation Summit:

September 24-25, 2026 -...